RIVASTIGMINE 4.5 MG CAPSULE

RIVASTIGMINE TARTRATE
$0.3653per EA
High Outlier

Strength

4.5 mg/1

NDC

75834013560

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

11/20/2019

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203844

On Market Since

9/4/2017

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-50.8%